메뉴 건너뛰기




Volumn 286, Issue 6, 2011, Pages 4703-4717

Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMOR ACTIVITIES; BIOPHYSICAL PROPERTIES; CLINICAL EVALUATION; IN-VIVO; INHIBITORY MECHANISM; INSULIN-LIKE GROWTH FACTOR RECEPTORS; LIGAND CONCENTRATION; MOLECULAR TARGETS; MONOCLONAL ANTIBODIES (MABS); NUDE MICE; PHARMACOKINETIC PROFILES; THERMAL STABILITY; TUMOR CELL LINES; TUMOR CELLS; TUMOR GROWTH;

EID: 79953016709     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M110.184317     Document Type: Article
Times cited : (37)

References (52)
  • 1
    • 0012373437 scopus 로고    scopus 로고
    • (Bast, R. C., Kufe, D. W., Pollock, R. E., Weichselbaum, R. R., Holland, J. F., and Frei, E., eds) 5th Ed., People's Medical Publishing House-U.S.A., Shelton, CT
    • Fedi, P., Kimmelman, A., and Aaronson, S. A. (2000) in Holland-Frei Cancer Medicine (Bast, R. C., Kufe, D. W., Pollock, R. E., Weichselbaum, R. R., Holland, J. F., and Frei, E., eds) 5th Ed., pp. 33-55, People's Medical Publishing House-U.S.A., Shelton, CT
    • (2000) Holland-Frei Cancer Medicine , pp. 33-55
    • Fedi, P.1    Kimmelman, A.2    Aaronson, S.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.